New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
About this Condition: Acute Myeloid Leukemia
Acute Myeloid Leukemia: About This Condition
Leukemia is a cancer of the blood. In leukemia, normal blood cells are transformed in ways that lead to high counts of white blood cells. The term “acute” means that the disease progresses rapidly.
Myeloid leukemia develops from cells that give rise to white blood cells called granulocytes and monocytes. The main function of granulocytes is to destroy bacteria.
In acute leukemias, which develop quickly, the cancerous cells (called blasts) are immature and incapable of performing their immune system functions. That can leave people vulnerable to infections.
Acute myeloid leukemia (AML) is also known as acute myelogenous leukemia. It is a fast-growing, aggressive condition. It is the most common kind of acute leukemia in adults.
INTERESTED IN AN ONLINE SECOND OPINION?
The Stanford Medicine Online Second Opinion program offers you easy access to our world-class doctors. It’s all done remotely, and you don’t have to visit our hospital or one of our clinics for this service. You don’t even need to leave home!
Visit our online second opinion page to learn more.
Clinical Trials for Acute Myeloid Leukemia (AML)
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.
To schedule an appointment, please call: 888-888-8888
Learn More About Acute Myeloid Leukemia
Patient Care Resources
Learn what to expect as you go through the early steps of your care.